Use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) appears to lower the incidence of basal cell and squamous cell carcinoma among people at high risk, according to a study among US veterans. Reuters Health Information
Switching to another tumor necrosis factor (TNF)-alpha antagonist is more likely than not to be successful in patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA) who fail to respond to an initial TNF-blocker. Reuters Health Information
Researchers describe adverse dermatologic effects in the scrotal and inguinal areas in 5 of 40 patients taking sunitinib for renal cell carcinoma. Medscape Medical News
An FDA safety review showed a 5-fold increased risk for cancer mortality in patients exposed to 3 or more tubes of becaplermin gel. Medscape Medical News
This paper reviews the consensus guidelines for the treatment of radiation dermatitis in patients with squamous cell carcinoma of the head and neck receiving EGFR inhibitors plus radiotherapy. Annals of Oncology
